Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Walgreens Boots Alliance
(NQ:
WBA
)
10.39
-0.34 (-3.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Walgreens Boots Alliance
< Previous
1
2
3
4
5
6
7
8
9
...
47
48
Next >
Trump Media, CXApp, Micron Technology, Walgreens, Tesla: Why These 5 Stocks Are On Investors' Radars Today
April 01, 2024
Monday's trading session saw a mixed performance in the U.S. stock market. The Dow Jones Industrial Average fell over 240 points, trading down 0.6% to 39,566.85
Via
Benzinga
Topics
Government
Stocks
Exposures
Political
US Equities
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 01, 2024
Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via
Benzinga
The Bargain Hunter’s Dream: 3 Underpriced Stocks Poised for Massive Gains
April 01, 2024
Uncover strategic moves by three pharma giants poised to capture trends and fulfill emerging healthcare needs.
Via
InvestorPlace
A Closer Look at Walgreens Boots Alliance's Options Market Dynamics
April 01, 2024
Via
Benzinga
3 Dow Stocks to Sell in April Before They Crash & Burn
April 01, 2024
These three DOW stocks to sell in April don't hold much promise for long-term investors. It's time to remove them from your portfolio.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Investor Sentiment Edges Lower, US Stocks Record Gains Last Quarter
April 01, 2024
The CNN Money Fear and Greed index showed a slight decline in overall market sentiment, but it remained in the "Greed" zone on Thursday. U.S. stocks closed mixed on Thursday, while the S&P 500 surged...
Via
Benzinga
1 Reason to Buy Walgreens, 1 Reason to Sell, and a Better High-Yield Stock to Buy Either Way
April 01, 2024
More growth than expected and a massive cost-cutting effort are under way. But there are still serious concerns.
Via
The Motley Fool
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
March 31, 2024
Over the past 12 months, 10 Large-Cap stocks have underperformed all others.
Via
Talk Markets
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
March 31, 2024
Which dividend-paying healthcare stock is better positioned to produce a rapidly growing payout?
Via
The Motley Fool
Wire Buzzers: 3 Stocks Making Headlines You Can’t Ignore
March 30, 2024
Here are three stocks making headlines in the current market, offering attractive opportunities this Easter trading season.
Via
InvestorPlace
A Lifetime of Passive Income Is Hiding in Plain Sight
March 30, 2024
Real estate you visit frequently could supply you with a lifetime of passive income.
Via
The Motley Fool
7 Dividend Stocks to Secure Your Financial Freedom by 2026
March 29, 2024
Explore seven dividend stocks for financial freedom in banking, insurance, construction, pharmaceuticals, and telecommunications.
Via
InvestorPlace
7 Blue-Chip Stocks to Buy at a 52-Week Low in March
March 28, 2024
Investors looking for blue-chip stocks to buy for long-term growth in their portfolio should pick-up these stocks while they are on sale.
Via
InvestorPlace
The Dow’s Crown Jewels: 3 Stocks Poised for Unbeatable Returns
March 28, 2024
The DJIA has been the bellwether index for well over a century and these stocks poised for unbeatable returns.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Why Walgreens Boots Alliance Stock Trounced the Market Today
March 28, 2024
The company notches convincing beats on headline fundamentals in its second-quarter earnings report.
Via
The Motley Fool
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
March 28, 2024
In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions.
Via
Benzinga
Walgreens Is Paying A Hefty Cost For Its Healthcare Transformation But It's Not Giving Up Despite Scary Competition From Amazon
March 28, 2024
Like Amazon.com Inc (NASDAQ: AMZN), Walgreens Boots Alliance (NASDAQ: WBA) is going for its piece of the healthcare pie.
Via
Benzinga
Gold Gains 1%; Walgreens Narrows Earnings Forecast
March 28, 2024
U.S. stocks traded slightly higher midway through trading, with the S&P 500 gaining around 0.1% on Thursday. The Dow traded up 0.06% to 39,785.87 while the NASDAQ rose 0.06% to 16,408.04. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
WBA Stock Earnings: Walgreens Boots Alliance Beats EPS, Beats Revenue for Q2 2024
March 28, 2024
WBA stock results show that Walgreens Boots Alliance beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Walgreens Boots Alliance Shows Resilience In Q2 With $37.1B In Sales
March 28, 2024
Walgreens Boots Alliance demonstrated resilience and adaptability in its fiscal Q2, with a 6.3 percent increase in sales.
Via
Talk Markets
Walgreens Beats Estimates In Fiscal Q2
March 28, 2024
Walgreens Boots Alliance Inc. is trading slightly up in premarket on Thursday after reporting upbeat financial results for its second quarter.
Via
Talk Markets
Walgreens Boots Alliance Cuts Higher End Of 2024 Profit Outlook, Takes $5.8B Impairment Charge Related To VillageMD Business
March 28, 2024
Walgreens Boots Alliance's Q2 FY24 performance: Sales rise 6.3% to $37.1 billion, beating estimates. Adjusted EPS up 3.4% at $1.20. Notable growth in Pharmacy segment, despite retail challenges....
Via
Benzinga
Wall Street Eyes Muted Open As Caution Prevails Before Key Inflation Data: Analyst Sees Buying Opportunities In Any Pullback
March 28, 2024
Following Wednesday’s late surge that pushed the S&P 500 Index to a record high, the market sentiment has shifted to cautious.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Earnings Scheduled For March 28, 2024
March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Via
Benzinga
RH, Walgreens And 3 Stocks To Watch Heading Into Thursday
March 28, 2024
With U.S. stock futures trading slightly lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Optimism Improves; S&P 500 Settles At New Record
March 28, 2024
The CNN Money Fear and Greed index showed some improvement in overall market sentiment on Wednesday, but it remained in the "Greed" zone. U.S. stocks closed higher on Wednesday, with the S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
March 28, 2024
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is expected to release earnings results for its second quarter, before the opening bell on March 28, 2024.
Via
Benzinga
Participation Broadens As The Equal Weight S&P Rips, WBA Earnings
March 27, 2024
It’s getting harder and harder to make a bearish technical case against stocks.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business Contract
March 27, 2024
Walgreens Boots Alliance challenges a nearly $1 billion arbitration award issued to telemedicine provider PWNHealth, alleging excessive damages under contract terms. The dispute revolves around...
Via
Benzinga
Exposures
COVID-19
What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?
March 27, 2024
Japan approves AstraZeneca & Sanofi's Beyfortus for respiratory syncytial virus in neonates, infants, & children. Also, Truqap receives approval for unresectable or recurrent breast cancer. AstraZeneca...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
47
48
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.